Abstract Details

Title Natalizumab in Multiple Sclerosis: A 'Drug Holiday' Is Less Well Tolerated Than a Regimen of Every Other Month Dosing

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 194

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Siddharama Pawate, MD (Vanderbilt University Medical Center)	The institution of Dr. Pawate has received research support from Genentech. The institution of Dr. Pawate has received research support from Biogen.
Christoph Mayer	No disclosure on file
Harold Moses, MD (Vanderbilt Multiple Sclerosis Center)	No disclosure on file
Subramaniam Sriram, MD (Vanderbilt University Medical Center)	Dr. Sriram has nothing to disclose.
	No disclosure on file

��ɫ��